|
|
 |
Javelin Pharma to Reduce Workforce by 15 Percent |
 |
Javelin Pharmaceuticals, Inc. (Amex: JAV), a leading developer of novel products for pain management, today announced that it will reduce its workforce by approximately 15 percent. The reduction is intended to reduce Javelin's cost structure. "We have taken difficult, but necessary actions, to reduce fixed costs across
|
|
 |
|
 |
|
 |
Rexam - Interim Management Statement |
 |
Group results for the four months ended 31 October, including the positive effect of currency translation, were in line with our expectations, and our outlook for 2008 remains unchanged. Performance in our Beverage Can business was solid. Despite a poor European summer, there was good growth throughout the region except in Russia where we are seeing
|
|